---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-019153"
form_type: "8-K"
ticker: "BNBX"
cik: "0000744452"
company_name: "BNB PLUS CORP."
filed_at: "2025-02-28T23:59:59+00:00"
generated_at: "2026-05-26T00:40:44.516772+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.55
calibrated_materiality_score: 0.15
confidence: "medium"
source: SEC EDGAR
---

# Applied DNA Sciences special meeting fails quorum; warrant approval delayed

## Summary
- Reconvened special meeting on Feb 28, 2025, had only 16,413,535 shares present, short of one-third outstanding requirement.
- No action taken on proposal to approve exercise of Series C & D warrants from October 2024 offering.
- Company is obligated to call another stockholder meeting to seek warrant stockholder approval.

## SEC filing metadata
- accession: 0001104659-25-019153
- form_type: 8-K
- ticker: BNBX
- cik: 0000744452
- company_name: BNB PLUS CORP.
- filed_at: 2025-02-28T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.55
- calibrated_materiality_score: 0.15
- confidence: medium
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/744452/000110465925019153/0001104659-25-019153-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/744452/000110465925019153/tm257916d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-019153
- JSON: https://secwatch.observer/filing/0001104659-25-019153.json
- Plain text: https://secwatch.observer/filing/0001104659-25-019153.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.